Recent News

Share
Print
and/or
455 News Items found
In the Lab
MSK immunologist Ming Li.
MSK-led Studies Support the Concept of “Cancer Environment Immunotherapy”
Targeting the cancer environment, rather than the cancer itself, could be a new avenue for immunotherapy.
Q&A
MSK developmental biologist Lorenz Studer
Taking Aim at Parkinson’s Disease: A Conversation with Developmental Biologist Lorenz Studer
In an interview in September 2020, Dr. Studer spoke about what he hopes he and his fellow investigators can accomplish with this generous support.

Promising GSK Students Awarded Doctoral Support for 2020-21 Academic Year

GSK congratulates ten of its doctoral students who have been recognized by esteemed organizations for their promising academic research.

  • Thursday, October 8, 2020
Regulatory proteins (gold balls) bind to enhancer regions (light blue) and promoter regions (pink) of DNA to form clusters that enable transcription (purple).
Going the Distance: How DNA Enhancers Communicate with Their Target Genes
Scientists at the Sloan Kettering Institute are learning how far-flung regions of genes connect to start the process of making proteins.

GSK Students Receive Fellowships for the 2020–2021 Academic Year

Meet the students who were awarded fellowships based on academic excellence for the 2020–2021 academic year.

  • Thursday, September 17, 2020
Article
An illustration of a beta-amyloid plaque among the neurons in a brain.
MSK Study Links Inflammation to Alzheimer’s Disease Development
An enzyme that contributes to plaque formation in the brain also serves as a first line of defense against bacteria and viruses, suggesting a link between the two.
MSK molecular geneticist Elli Papaemmanuil.
Large International Study Pinpoints Impact of TP53 Gene Mutations on Blood Cancer Severity
Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.

2020 GSK Chairman’s Prize Recognizes Research Exploring New Immunotherapy Approach for Age-Related Inflammatory Diseases

Meet Corina Amor Vegas, a fourth-year student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), who has been awarded the 2020 Chairman’s Prize.

  • Friday, July 31, 2020
Charles Sawyers in his lab
A New Approach in Prostate Cancer: Targeting the Cells Surrounding the Tumor
Scientists have found a protein that empowers prostate tumors to resist hormone therapy.
MSK physician-scientists Michael Glickman and Gil Redelman-Sidi
The ABCs of BCG: Oldest Approved Immunotherapy Gets New Explanation
BCG has been used to treat bladder cancer for more than 30 years. Scientists are still learning how it works.